Landscapes / Companies
ScinnoHub Pharmaceutical Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
1 in Phase 1
Drugs
3
in active trials
Trials
4 active
6 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 31 Dec 2026Phase 2 trial completes | |||
| Next date | 31 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Total Knee Arthroplasty | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Sep 2027Phase 2 trial completes | |||
| Next date | 30 Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Hemoglobinopathy, Thalassemia | ||||
| Open drug page | |||||
— |
Phase 1 | 26 Jun 2027Phase 1 trial completes | |||
| Next date | 26 Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021